ARTICLE | Company News
Arena, Suzhou Connect Biopharmaceuticals deal
July 30, 2012 7:00 AM UTC
Chinese company Suzhou Connect said it received an exclusive, worldwide license from Arena to develop and commercialize preclinical small molecule compounds to treat allergic rhinitis and atopic derma...